ArticleRMD open2025
Machine learning using genotype and gene-expression data identifies alterations of genes involved in infection susceptibility, antigen presentation and cytokine signalling as key contributors to JIA risk prediction.
Article in RMD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efforts towards a precision medicine approach in juvenile idiopathic arthritis.Rheumatology (Oxford, England) · 2026Review
- From arthritis to central sensitization: targeting the neuro-immune axis via microglial modulation in acupuncture treatment for Juvenile Idiopathic Arthritis-associated pain.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPrevious genome-wide association studies (GWAS) have identified numerous genetic loci associated with juvenile idiopathic arthritis (JIA). However, the functional impact of these variants-particularly on tissue-specific gene expression-and which regulatory interactions make the greatest relative contribution to JIA risk remain unclear. Identifying these key single-nucleotide polymorphism (SNP)-gene-tissue combinations can help prioritise targets for future functional studies and therapeutic interventions.
methodWe performed two-sample Mendelian randomisation (2SMR) using spatial expression quantitative trait loci (eQTLs) from nine tissue-specific gene-regulatory networks as instrumental variables (IVs). We also identified JIA-associated SNPs from previous GWAS and mapped their spatial eQTL effects across 49 human tissues. These SNP sets were then used as features in a Lasso-regularised logistic regression model to predict JIA disease status. The model weight magnitudes served as proxies for each SNP's contribution to JIA risk. We evaluated the robustness of our model's feature ranking across 50 cross-validation runs.
resultsThe top-ranked SNPs included rs7775055, which tags the human leukocyte antigen (HLA) class II haplotype
conclusionBy applying a machine learning approach to rank SNP-gene-tissue contributions to JIA risk, our findings offer insights into the genetic mechanisms underlying JIA pathogenesis. Future experimental validation could facilitate new therapeutic targets for the treatment or prevention of JIA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.